Analysis of a metalloporphyrin antioxidant mimetic (MnTE-2-PyP) as a radiomitigator: prostate tumor and immune status.

Mehrotra, S; Pecaut, M J; Freeman, T L; Crapo, J D; Rizvi, A; Luo-Owen, X; Slater, J M; Gridley, D S

Mehrotra, S; Pecaut, M J; Freeman, T L; Crapo, J D; Rizvi, A; Luo-Owen, X; Slater, J M; Gridley, D S.

Affiliation

Mehrotra S; Department of Basic Sciences, Divisions of Biochemistry and Microbiology, Loma Linda University and Medical Center, Loma Linda, CA, USA.

Technol Cancer Res Treat ; 11(5): 447-57, 2012 Oct.

Article in En | MEDLINE | ID: mdl-22475066

Subject(s)

Antioxidants/administration & dosage; Metalloporphyrins/administration & dosage; Prostatic Neoplasms/radiotherapy; Radiation-Protective Agents/administration & dosage; Animals; Blood Cell Count; Male; Metalloporphyrins/chemistry; Mice; Mice, Inbred C57BL; Molecular Mimicry; Organ Size; Prostatic Neoplasms/immunology; Prostatic Neoplasms/pathology; Radiation Injuries, Experimental/prevention & control; Spleen/drug effects; Spleen/pathology; Spleen/radiation effects; Superoxide Dismutase/chemistry; Tumor Burden/drug effects; Tumor Burden/radiation effects; Whole-Body Irradiation; Xenograft Model Antitumor Assays

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Radiation-Protective Agents / Metalloporphyrins / Antioxidants Limits: Animals Language: En Journal: Technol Cancer Res Treat Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links